BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36641997)

  • 1. A t(4;13)(q21;q14) translocation in B-cell chronic lymphocytic leukemia causing concomitant homozygous DLEU2/miR15a/miR16-1 and heterozygous ARHGAP24 deletions.
    Tolomeo D; Agostini A; Solimando AG; Cunsolo CL; Cimarosto L; Palumbo O; Palumbo P; Carella M; Hernández-Sánchez M; Hernández-Rivas JM; Storlazzi CT
    Cancer Genet; 2023 Apr; 272-273():16-22. PubMed ID: 36641997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of MIR15A and MIR16-1 at 13q14 is associated with increased TP53 mRNA, de-repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia.
    Lin K; Farahani M; Yang Y; Johnson GG; Oates M; Atherton M; Douglas A; Kalakonda N; Pettitt AR
    Br J Haematol; 2014 Nov; 167(3):346-55. PubMed ID: 25040181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation (6;13)(p21;q14.1) as a rare nonrandom cytogenetic abnormality in chronic lymphocytic leukemia.
    Karakosta M; Voulgarelis M; Vlachadami I; Manola KN
    Cancer Genet Cytogenet; 2010 Apr; 198(1):66-70. PubMed ID: 20303017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
    Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
    Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
    Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
    Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
    Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
    Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia.
    Gardiner AC; Corcoran MM; Oscier DG
    Genes Chromosomes Cancer; 1997 Sep; 20(1):73-81. PubMed ID: 9290957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocations as a mechanism for homozygous deletion of 13q14 and loss of the ATM gene in a patient with B-cell chronic lymphocytic leukemia.
    Herholz H; Kern W; Schnittger S; Haferlach T; Dicker F; Haferlach C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):57-60. PubMed ID: 17350468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1q23.1 homozygous deletion and downregulation of Fc receptor-like family genes confer poor prognosis in chronic lymphocytic leukemia.
    Daniele G; L'Abbate A; Turchiano A; Palumbo O; Carella M; Lo Cunsolo C; Iuzzolino P; Lonoce A; Hernández-Sánchez M; Minoia C; Leone P; Hernandez-Rivas JM; Storlazzi CT
    Clin Exp Med; 2019 May; 19(2):261-267. PubMed ID: 30877410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare but recurrent t(8;13)(q24;q14) translocation in B-cell chronic lymphocytic leukaemia causing MYC up-regulation and concomitant loss of PVT1, miR-15/16 and DLEU7.
    Macchia G; Lonoce A; Venuto S; Macrí E; Palumbo O; Carella M; Lo Cunsolo C; Iuzzolino P; Hernández-Sánchez M; Hernandez-Rivas JM; Storlazzi CT
    Br J Haematol; 2016 Jan; 172(2):296-9. PubMed ID: 26010203
    [No Abstract]   [Full Text] [Related]  

  • 11. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
    Migliazza A; Bosch F; Komatsu H; Cayanis E; Martinotti S; Toniato E; Guccione E; Qu X; Chien M; Murty VV; Gaidano G; Inghirami G; Zhang P; Fischer S; Kalachikov SM; Russo J; Edelman I; Efstratiadis A; Dalla-Favera R
    Blood; 2001 Apr; 97(7):2098-104. PubMed ID: 11264177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression analysis of genes located in the minimally deleted regions of 13q14 and 11q22-23 in chronic lymphocytic leukemia-unexpected expression pattern of the RHO GTPase activator ARHGAP20.
    Herold T; Jurinovic V; Mulaw M; Seiler T; Dufour A; Schneider S; Kakadia PM; Feuring-Buske M; Braess J; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Bohlander SK
    Genes Chromosomes Cancer; 2011 Jul; 50(7):546-58. PubMed ID: 21500311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of 13q14.3 deletion by cytogenetic analysis and FISH technique and miRNA-15a and miRNA-16-1 by real time PCR in chronic lymphocytic leukemia.
    Yılmaz M; Kuru RD; Erdoğan I; Soysal T; Hacıhanefioglu S; Baykara O
    Afr Health Sci; 2022 Sep; 22(3):173-182. PubMed ID: 36910369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.
    Ouillette P; Collins R; Shakhan S; Li J; Li C; Shedden K; Malek SN
    Clin Cancer Res; 2011 Nov; 17(21):6778-90. PubMed ID: 21890456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2 level as a biomarker for 13q14 deletion in CLL.
    Degheidy HA; Gadalla SM; Farooqui MZ; Abbasi F; Arthur DC; Bauer SR; Wilson WH; Wiestner A; Stetler-Stevenson MA; Marti GE
    Cytometry B Clin Cytom; 2013; 84(4):237-47. PubMed ID: 23674504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.
    Döhner H; Stilgenbauer S; Döhner K; Bentz M; Lichter P
    J Mol Med (Berl); 1999 Feb; 77(2):266-81. PubMed ID: 10023780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study.
    Bigoni R; Cuneo A; Roberti MG; Bardi A; Rigolin GM; Piva N; Scapoli G; Spanedda R; Negrini M; Bullrich F; Veronese ML; Croce CM; Castoldi G
    Leukemia; 1997 Nov; 11(11):1933-40. PubMed ID: 9369429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased genomic alteration complexity and telomere shortening in B-CLL cells resistant to radiation-induced apoptosis.
    Salin H; Ricoul M; Morat L; Sabatier L
    Cytogenet Genome Res; 2008; 122(3-4):343-9. PubMed ID: 19188704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the pathogenesis of chronic lymphocytic leukemia.
    Klein U; Dalla-Favera R
    Semin Cancer Biol; 2010 Dec; 20(6):377-83. PubMed ID: 21029776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia.
    Panayiotidis P; Ganeshaguru K; Rowntree C; Jabbar SA; Hoffbrand VA; Foroni L
    Br J Haematol; 1997 Jun; 97(4):844-7. PubMed ID: 9217187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.